During the exposure window, in the albumin-corrected serum calcium cohort and the phosphate and calcium-phosphate cohort, the first documented CKD diagnosis in patients was at stage 3 in 97.3% and 92.5% of patients, stage 4 in 2.0% and 7.5%, and stage 5 in 0.7% and 0%, respectively. The gene discussed is ALB; the disease is chronic kidney disease.